Genes & biomarkers
ROS1 fusions
ROS1 · fusion / rearrangement
A gene fusion relevant to treatment in some lung cancers.
Sources checked · Introductory guide
On this page
What does this result mean?
ROS1-positive non-small cell lung cancer has a ROS1-related treatment target. A mention of ROS1 on a report is not by itself a qualifying positive result.[1]
How does it connect to treatment?
In the US, entrectinib is used for adults with ROS1-positive metastatic non-small cell lung cancer. Treatment planning also reviews previous targeted drugs and sites of disease.[1]
What should I check in my report?
Ask whether a fusion/rearrangement was confirmed and by which method. Check whether a VUS or protein-expression result meets the same treatment criteria.
Questions for your care team
- Does my ROS1 result confirm a treatment-relevant fusion?
- Which treatments or trials fit my cancer type, stage and previous treatment?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.